Most anti-aging claims are about how you feel, but hyperbaric oxygen therapy (HBOT) focuses on a quantifiable aspect of human aging. This involves measuring the length of telomeres, the protective caps on the ends of your chromosomes that shorten as you age, and the buildup of senescent cells. These so-called “zombie cells” stop dividing but stick around, contributing to inflammation and other aspects of cellular senescence.
In 2020, researchers in Israel published a groundbreaking human study demonstrating that HBOT could measurably reverse telomere shortening and reduce the presence of these senescent cells.
This suggests a promising new avenue for addressing biological aging and its biomarkers by enhancing mitochondrial function and improving oxygenation at the cellular level.
Recent studies have uncovered the fascinating effects of hyperbaric oxygen therapy (HBOT) on aging, particularly focusing on telomeres, one of the key biomarkers of aging.
Telomeres act like the plastic tips at the end of shoelaces, preventing chromosomal ends from deteriorating or fusing with adjacent chromosomes. As cells divide, telomeres gradually shorten, eventually leading to cell senescence or cell death. This has made telomere length a critical factor in researching biological aging and human longevity.
Their length is considered an aging biomarker, with shorter telomeres linked to age-related diseases.
Senescent cells, sometimes called “zombie cells,” stop dividing but do not die. Accumulating over time after millions of cell cycles, they release inflammatory signals, contributing to chronic inflammation and tissue damage. This process, known as cellular senescence, is a hallmark of aging. By reducing the number of senescent cells, hyperbaric oxygen therapy may effectively combat inflammation and improve tissue regeneration.
HBOT involves breathing pure oxygen in a pressurized hyperbaric chamber, significantly increasing oxygenation at the cellular level. This environment promotes hyperoxia, enhancing mitochondrial function and oxidative capacity. A critical study showcased in 2020, reported that HBOT could increase telomere length and decrease senescent cell accumulation. Such findings suggest that hyperbaric oxygen therapy may serve as a viable anti-aging intervention, offering potential in reversing age-related cellular damage and supporting overall longevity.
Recent studies have explored the potential anti-aging effects of hyperbaric oxygen therapy (HBOT). A notable study from Tel Aviv University and the Sagol Center for Hyperbaric Medicine, led by Dr. Shai Efrati, indicated significant findings related to hyperbaric oxygen’s influence on aging biomarkers. The therapy involved 35 healthy, independently-living adults aged 64 and older.
After a defined course of HBOT, blood analysis showed telomere length had increased by as much as 38% in certain immune cell populations, enough, researchers noted, that some participants’ telomeres were comparable in length to where they’d been roughly 25 years earlier. Senescent cell counts dropped by up to 37% over the same period.
The study used 60 hyperbaric oxygen sessions at 2 ATA, 90 minutes each, five days a week over about three months, with brief air breaks built into each session to manage oxygen exposure safely. Blood samples were drawn at baseline, at the 30th and 60th sessions, and again 1–2 weeks after the final hyperbaric oxygen session to confirm the changes weren’t temporary.
Telomere shortening and cellular senescence are two of the most well-established biological hallmarks of aging. Both contribute to age-related disease risk, including cardiovascular disease and cognitive decline. Researchers have described telomere elongation specifically as a long-sought target in longevity research, with pharmaceutical approaches still in early development. Hyperbaric oxygen therapy might be the answer to the search for a non-pharmacological intervention that measurably moves these markers in humans.
This finding builds on a broader body of Sagol Center research using the same core protocol (2 ATA, 90-minute hyperbaric oxygen sessions with air breaks), which has shown improvements in cognitive function and physical capabilities in aging and post-injury populations. Related animal research supports the biological plausibility of HBOT’s mechanism, showing it can restore telomere length in brain tissue. This expands our understanding of how hyperbaric oxygen therapy might influence human aging.
While the findings are promising, HBOT is not considered an anti-aging cure. This was a proof-of-concept study in a relatively small, healthy cohort, focusing on cellular biomarkers rather than long-term clinical outcomes like disease incidence or lifespan. It establishes that hyperbaric oxygen therapy can impact two core aging mechanisms in humans, encouraging further research into its potential benefits for reversing aging processes and improving longevity.
Beyond its potential anti-aging effects by slowing down telomere shortening, hyperbaric oxygen therapy (HBOT) offers an array of other health benefits, supported by research and clinical applications. One significant advantage is its impact on wound healing.
Incorporating hyperbaric oxygen therapy into a holistic health regimen may offer a multi-faceted approach to improving longevity and overall well-being, targeting both the visible and underlying markers of aging.
This hyperbaric oxygen therapy research was conducted entirely at 2 ATA, a pressure only hard-shell, hospital-grade hyperbaric chambers are built to reach and safely sustain. This high level of oxygen partial pressure supports biological aging studies by enhancing oxygenation and potentially reversing telomere shortening. Notably, these hyperbaric chambers facilitate greater oxygen therapy exposure compared to mild, low-pressure wellness chambers. Our Fortius chamber, reaching 2.0–2.2 ATA, mirrors the operating pressures used throughout this oxygenation research program, addressing aspects like mitochondrial function and inflammation.
Before any hyperbaric oxygen therapy (HBOT) session, there are several preparatory steps to ensure safety and maximize benefits:
Furthermore, post-hyperbaric oxygen therapy guidelines are designed to optimize the benefits of the treatment and ensure recovery:
If cellular-level aging biomarkers are part of what you’re paying attention to in your own longevity strategy, this is one of the more rigorously documented areas of HBOT research to know about. Our team can walk you through what a hyperbaric oxygen therapy protocol modeled on this research actually looks like, and set realistic expectations for what it can and can’t tell you about your own aging process.
This article summarizes a single published human study and related research for educational purposes. It is not medical advice, and HBOT protocols should be discussed with your physician.